Antiplatelet Therapy (e.g., Aspirin)
Treatment for Vascular Dementia
Typical Dosage: 75-325 mg daily (typically 81mg or 100mg)
Effectiveness
78%
Safety Score
80%
Clinical Trials
300
Participants
80K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
80
DangerousModerateSafe
Treatment Details
Dosage Range
75-325 mg daily (typically 81mg or 100mg)
Time to Effect
Immediate for antiplatelet effect, long-term for preventive benefits
Treatment Duration
Lifetime
Evidence Quality
HIGHNumber Needed to Treat (NNT)
70(Treat 70 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
250(Treat 250 patients to see 1 additional serious adverse event)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$20
Monitoring:$50
Side Effect Mgmt:$30
Total Annual:$100
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$5,000/QALY
QALYs Gained
0.15
Outcome-Based Costs
Cost per Responder
$200
Antiplatelet Therapy (e.g., Aspirin) Outcomes
for Vascular Dementia
Efficacy Outcomes
Overall Effectiveness
+78%
Response Rate
+50%
Common Side Effects
GI upset/heartburn
+7%
Minor bleeding (nosebleeds, bruising)
+3%
Major GI bleed
+0.5%
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov